The HCPLive Psychiatry condition center page is a comprehensive resource for clinical news and insights on mental illnesses. This page consists of interviews, articles, podcasts, and videos on the research, treatment and development of therapies for depression, schizophrenia, bipolar disorder, anxiety, and more.
November 29th 2024
A study found patients with schizophrenia exhibiting violence, vs. those who don’t, have less gray matter volume in the frontal lobe and greater thyroid-stimulating hormone levels.
November 26th 2024
SimulatED™: Diagnosing and Treating Alzheimer’s Disease in the Modern Era
View More
Clinical Consultations™: Managing Depressive Episodes in Patients with Bipolar Disorder Type II
View More
Medical Crossfire®: Understanding the Advances in Bipolar Disease Treatment—A Comprehensive Look at Treatment Selection Strategies
View More
'REEL’ Time Patient Counseling: The Diagnostic and Treatment Journey for Patients With Bipolar Disorder Type II – From Primary to Specialty Care
View More
Q&A With Addiction Treatment Specialistis, Joseph R. Volpicelli, MD, PhD, and Tracy Steen, PhD
February 11th 2008Joseph R. Volpicelli, MD, PhD, is an associate professor in the Department of Psychiatry at the University of Pennsylvania School of Medicine, and a Senior Scientist at the Penn Center for Studies of Addiction. Tracy Steen, PhD, is Clinical Director at the Charles O'Brien Center for Addiction Treatment, University of Pennysylvania.
The Ultimate Timewaster's Guide to the Internet
February 8th 2008We know you're busy. But even doctors find themselves with a little time to kill every now and then. When this happens, we suppose you could do something like read a book or talk with a friend or family member, but who wants to do that?
ADHD as a Diagnostic Chameleon: Developing a Systematic Approach to Differential Diagnosis
February 8th 2008ADHD is a common presentation in all clinical settings. However, data shows that ADHD is underrecognized in adults.1 Why is this? Remember the old adage, "Out of sight, out of mind?" If ADHD is not thought of as a possibility in adult patients, is it more likely to be missed?
Perspectives on Efficacy: An Atomoxetine Tutorial
February 8th 2008This article provides answers to several common questions associated with the use of Strattera® (atomoxetine HCl) to treat patients with ADHD. Strattera is indicated for the treatment of Attention-Deficit/Hyperactivity Disorder (ADHD) in children age 6 and older, adolescents, and adults.